Lifestyle intervention to improve quality of life and prevent weight gain after renal transplantation:Design of the Active Care after Transplantation (ACT) randomized controlled trial by Klaassen, Gerald et al.
  
 University of Groningen
Lifestyle intervention to improve quality of life and prevent weight gain after renal
transplantation
Klaassen, Gerald; Zelle, Dorien M; Navis, Gerjan J; Dijkema, Desie; Bemelman, Frederike J;





IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2017
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Klaassen, G., Zelle, D. M., Navis, G. J., Dijkema, D., Bemelman, F. J., Bakker, S. J. L., & Corpeleijn, E.
(2017). Lifestyle intervention to improve quality of life and prevent weight gain after renal transplantation:
Design of the Active Care after Transplantation (ACT) randomized controlled trial. Bmc nephrology, 18(1),
[296]. https://doi.org/10.1186/s12882-017-0709-0
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
STUDY PROTOCOL Open Access
Lifestyle intervention to improve quality of
life and prevent weight gain after renal
transplantation: Design of the Active Care
after Transplantation (ACT) randomized
controlled trial
Gerald Klaassen1* , Dorien M. Zelle1, Gerjan J. Navis1, Desie Dijkema2, Frederike J. Bemelman3,
Stephan J.L. Bakker1 and Eva Corpeleijn4
Abstract
Background: Low physical activity and reduced physical functioning are common after renal transplantation, resulting
in a reduced quality of life. Another common post-transplantation complication is poor cardio-metabolic health, which
plays a main role in long-term outcomes in renal transplant recipients (RTR). It is increasingly recognized that
weight gain in the first year after transplantation, especially an increase in fat mass, is a highly common contributor to
cardio-metabolic risk. The aim of this study is to compare the outcomes of usual care to the effects of exercise alone,
and exercise combined with dietary counseling, on physical functioning, quality of life and post-transplantation weight
gain in RTR.
Methods: The Active Care after Transplantation study is a multicenter randomized controlled trial with three arms in
which RTR from 3 Dutch hospitals are randomized within the first year after transplantation to usual care, to exercise
intervention (3 months supervised exercise 2 times per week followed by 12 months active follow-up), or to an exercise
+ diet intervention, consisting of the exercise training with additional dietary counseling (12 sessions over 15 months by
a renal dietician). In total, 219 participants (73 per group) will be recruited. The primary outcome is the subdomain
physical functioning of quality of life, (SF-36 PF). Secondary outcomes include other evaluations of quality of life (SF-36,
KDQOL-SF, EQ-5D), objective measures of physical functioning (aerobic capacity and muscle strength), level of physical
activity, gain in adiposity (body fat percentage by bio-electrical impedance assessment, BMI, waist circumference), and
cardiometabolic risk factors (blood pressure, lipids, glucose metabolism). Furthermore, data on renal function, medical
history, medication, psychological factors (motivation, kinesiophobia, coping style), nutrition knowledge, nutrition intake,
nutrition status, fatigue, work participation, process evaluation and cost-effectiveness are collected.
Discussion: Evidence on the effectiveness of an exercise intervention, or an exercise + diet intervention on physical
functioning, weight gain and cardiometabolic health in RTR is currently lacking. The outcomes of the present study may
help to guide future evidence-based lifestyle care after renal transplantation.
Trial registration: Number: NCT01047410.
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Background
Low physical activity, reduced physical fitness and reduced
physical functioning are common after renal transplant-
ation [1]. Physical activity levels decline already in the
early stages of chronic kidney disease, and reach a nadir at
end-stage renal disease [1]. This low physical activity ag-
gravates the catabolic state that is common in patients
with renal disease, which leads to deconditioning and re-
duced physical functioning [1]. Spontaneous recovery of
physical activity level after transplantation is modest, and
limited physical functioning remains common [1]. Like-
wise, low cardiorespiratory fitness and muscle weakness
are also common after renal transplantation [1]. This may
be improved with exercise and physical activity, however,
RTR experience barriers to engage in exercise and physical
activity such as fear of movement, lack of motivation, and
fatigue [1, 2].
The incidence and prevalence of cardiovascular disease
is estimated to be 4 to 6 times higher in RTR compared
to the general population [3]. Various factors may ex-
plain poor post-transplantation health in RTR, including
the legacy of end-organ damage due to the prior medical
history (e.g. cardiovascular damage), that may not be
fully reversible by restoring renal function. Importantly,
the common substantial post-transplantation weight
gain, which is primarily due to an increase in body fat
mass, is a major trigger for the poor cardio-metabolic
profile in the RTR, including post-transplant diabetes
and the metabolic syndrome [4–9]. Furthermore, post-
transplantation BMI is an important risk factor for graft
failure and premature death [10–13]. A poor diet post-
transplantation may be related to pre-transplantation
dietary prescriptions such as low intake of vegetables to
avoid hyperkalemia and a high intake of energy rich
drinks to ensure adequate energy intake [14, 15]. Add-
itionally, glucocorticoid use after transplantation often
promotes overeating, so a healthy diet without an excess
of calories is frequently required [16]. Data from a previ-
ous study showed that RTR gain an average of 5.7 ± 5.0
Kg of body weight in the first year after transplantation
(Fig. 1) [4]. Interestingly, the rise in body weight was re-
lated to low physical activity and poor diet rather than
increased energy intake [4].
From the above, it may be clear that both physical activ-
ity and diet are important targets for lifestyle intervention
in RTR. The importance of physical activity and exercise
for health outcomes is well-acknowledged in the general
population [17]. In RTR however, high level evidence on
the effects of physical activity and exercise on physical
functioning and cardiometabolic health is limited and
comes from few small RCTs [18, 19]. The available studies
however, including single group interventions, show prom-
ising results. Dietary intervention after renal transplant-
ation was shown to reduce body weight and improve lipid
profile [20], whereas intensive lifestyle intervention im-
proved glucose metabolism [21]. Importantly, it was also
Fig. 1 Changes in body weight and body composition after renal transplantation. (a: BMI, b: body fat percentage, c: fat-free mass, and d: whole
body water content) Reprinted from “The role of diet and physical activity in post-transplant weight gain after renal transplantation” by D.M. Zelle,
2013, Clinical Transplantation, 27: E484-E490. Reprinted with permission
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shown that a supervised exercise program lead to similar
improvements in muscle strength and aerobic capacity in
RTR compared to healthy individuals [22].The first year
after transplantation may provide a window of opportunity
to improve physical functioning and quality of life, and to
prevent post-transplantation weight gain and its cardiomet-
abolic consequences. Assuming that muscle disuse is a
major factor in muscle weakness and low aerobic capacity
in RTR, exercise rehabilitation and increased daily physical
activity may be of great benefit to this patient population.
For physical activity and exercise to result in a favourable
shift from a catabolic to an anabolic state, proper consider-
ation of nutritional status, in particular energy and protein
intake, and metabolic status is necessary. Furthermore,
dietary counseling directed at restoring a healthy eating
pattern may prevent post-transplant weight gain and im-
prove dietary quality.
The Active Care after Transplantation (ACT) study is
a pragmatic randomized controlled trial designed to
evaluate the effects of an exercise intervention, and an
exercise + dietary intervention, on physical functioning
and quality of life after renal transplantation. In addition,
detailed measures of physical fitness, level of physical ac-
tivity, gain in adiposity, renal function, and cardiometa-
bolic profile will be investigated, as well as success
factors for lifestyle change in RTR. A health economics
evaluation is included.
Methods/design
Active Care After Transplantation (ACT) is a multicen-
ter pragmatic randomized controlled trial in renal trans-
plant patients in the Netherlands, registered on
www.clinicaltrials.gov as NCT01047410. The ACT trial
has three study arms: usual care versus exercise inter-
vention versus exercise + diet intervention (Fig. 2). It is
designed according to the principles of a pragmatic RCT
to allow evaluation of the intervention in real-life care
facilities. Details are described below according to the
CONSORT statement for parallel randomized trials and
the extension of the CONSORT statement for pragmatic
trials [23–25]. The study is performed according to the
declaration of Helsinki and ethical approval is obtained
from the University Medical Center Groningen Medical
Ethics committee (NL49084.042.14). Adverse- and ser-
ious adverse events data are collected and closely moni-
tored to ensure the ongoing safety of the participants.
Both are reported in a standardized Adverse Events Re-
port Form. Exemption to report adverse events is given
for common renal transplant related co-morbidities,
such as cardiovascular events, urinary tract infections,
viral infections, pneumonia, urine retention, rejection,
cardiac decompensation, hydronephrosis, nephrostomy
catheter, lymphocele, hypertension, dyslipidemia, dia-
betes, post-transplantation lymphoma, cerebrovascular
accidents, meningitis, and skin cancer.
Eligibility criteria
The target population for the study are adult RTR,
recruited during routine post-transplantation care shortly,
but at least within the first year after transplantation.
Inclusion criteria are: written informed consent;
age > 18 years; < 1 year after transplantation; approval for
participation based on a general medical evaluation by
their nephrologist. Exclusion criteria included the follow-
ing: multiple organ transplantation; psychopathology or
serious cognitive impairment; physical or clinical limita-
tions that make participation impossible; pregnancy, nega-
tive screening verdict by the nephrologist or cardiologist.
Participants receive a small financial reimbursement (10
Euro) for participation in the final follow-up measurement
Fig. 2 Flowchart of the ACT trial
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at 15 months. Participation in the exercise training ses-
sions and dietary care are financed by research funds, and
participants’ travel expenses are reimbursed. Pre-defined
reasons to discontinue participation in the study included
pregnancy and conversion to dialysis. Furthermore, reasons
to discontinue participation are: changes in ECG during
maximal aerobic capacity testing, systolic blood pres-
sure > 250 mmHg, diastolic blood pressure > 120 mmHg
or blood pressure decline of > 20 mmHg during maximal
aerobic capacity testing, and severe cardio-pulmonary com-
plaints during the exercise trainings sessions.
Screening, recruitment and randomization
All RTR patients are screened for eligibility during the
post-transplantation recovery period, so within 7–10 days
after surgery, by the nephrologist. Eligible RTR are in-
vited to participate, informed about the study protocol
and if agreed are asked to participate and sign written
informed consent. In case of non-Dutch or non-English
speaking patients, interpreters are used.
In total, 219 participants (73 per group) will be re-
cruited. The sample size is based on the expected im-
provement on the physical functioning scale of quality of
life of 13.8 points in the intervention group and 8.8
points in usual care (α=0.05, β= 0.80, SD = 11.0) [26]. A
difference of 5.0 points between the standard effect is
considered a relevant effect. This results in a required
number of 57 RTR per group. Taking into account a po-
tential dropout rate of 15% and a correction for hetero-
geneity between centers of 10%, this results in a total
required number of 73 RTR per group (N = 219 in total).
Randomization to one of the three arms is computerized
using the ‘PROC SURVEYSELECT’ function in the soft-
ware program SAS (Cary, North Carolina, USA). It is
performed by an independent data management com-
pany hosting the data entry facility, who are not involved
in conducting the study itself (Nefrovisie foundation, Ut-
recht, the Netherlands). Participants are randomized by
block randomization in groups of 6–9 for rehabilitation
centers and in groups of 3 for physiotherapy practices.
Setting and participants
Recruitment takes place in three Dutch hospitals with
good geographical coverage, in the north (University
Medical Center Groningen), west (Amsterdam Medical
Center) and south (Maastricht University Medical Cen-
ter) of The Netherlands. The exercise training is offered
in rehabilitation centers or in local physiotherapy prac-
tices if there is no rehabilitation center within reasonable
travel distance of the residence of the participant.
Delivery of the exercise training is standardised by
providing protocols and the same exercise training
protocol for all interventionists.
Professionals
The interventionists of the participating centers all re-
ceived personal instructions of exercise scientists on the
protocols, the basic medicine of renal disease, and ad-
verse effects of the immunosuppressive- and other medi-
cation. Furthermore, all interventionists participated in a
mandatory kickoff meeting where the lifestyle counseling
part of the intervention was explained and practiced, in-
cluding the theoretical background (stages of change
model and motivational interviewing). All participating
rehabilitation centers and physiotherapy practices meet
the following criteria: expertise in rehabilitation of car-
diovascular or oncology patients; adequate training facil-
ities; all the necessary fitness equipment for submaximal
cycle ergometry and strength tests; and, for physiother-
apy practices only, provide opportunities for participants
to continue their fitness activities during the active
follow-up.
Concerning the diet intervention, dieticians are required
to meet the following selection criteria: experience in
counseling renal patients or other patients with a serious
chronic metabolic condition; educated and experienced in
motivational interviewing; educated and experienced in
Subjective Global Assessment of malnutrition. Lifestyle
coaches had to fulfill the following selection criteria:
experience in lifestyle counseling of renal patients or other
patients with a serious chronic metabolic condition; edu-
cated and experienced in motivational interviewing. In
most cases the lifestyle counseling is done by the physio-
therapist who supervises the training.
A website dedicated to the study (in Dutch language)
provides all protocols, explanations and hosts a data
entry system (www.act-studie.nl).
Usual care
Participants randomized to the usual care group receive
standard post-transplant care as usual in the hospitals.
Current standard nutrition care after kidney transplant-
ation consists of 1–4 inpatient consultations by a renal
dietitian during the inpatient stay (7–10 days), followed
by 1 outpatient consultation. During inpatient consulta-
tions attention is paid to optimal nutritional intake,
maintaining a stable body weight and muscle mass, or
increasing body weight when needed. After a few
months, during the outpatient follow-up, attention is
paid to maintaining a stable body weight, or increasing
or decreasing body weight when needed. When a partici-
pant has increased cholesterol, (un)saturated fat intake is
discussed, and mono/disaccharides are discussed when a
participant has increased HbA1c. Likewise, salt con-
sumption is discussed in case of increased 24-h sodium
excretion. Exercise or lifestyle counseling are not in-
cluded in the standard post-transplant care in either of
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the participating hospitals. Participants randomized to
the usual care group receive general advice to meet the
standard Dutch exercise guidelines (30 min of moderate
physical activity per day) and follow the Dutch Dietary
guidelines.
Exercise only intervention
The exercise intervention consists of two phases. The
first phase is a 3-month exercise training program,
followed by the second phase; a 12-month active follow-
up with lifestyle counseling (Figure 2). Exercise training
sessions are done in groups of 4–10 participants in the
rehabilitation centers and with 1–6 participants in the
physiotherapy centers.
The training program encompasses two exercise train-
ing sessions per week (21 exercise training sessions and
3 test sessions in total) and is focused on improving
maximal muscle strength, local muscle endurance, and
aerobic capacity. Each exercise training session consists
of 30-min dynamic resistance training of all the major
muscle groups (Additional file 1: Table S1) using resist-
ance training machines, 30 min of aerobic training
(cycle-ergometry and treadmill walking), and is con-
cluded with a 30-min supervised sports activity or swim-
ming, depending on the available facilities.
The dynamic resistance training includes both max-
imal strength training (relatively high load, fewer repeti-
tions), and muscle endurance training (relatively low
load, large number of repetitions).
Optimal resistance training load is determined using
one-repetition maximum testing (1RM) for each partici-
pant. The content of the training program is in line with
the American College of Sports Medicine guidelines ex-
ercise in healthy adults [27], and was previously shown
to be effective in improving muscle strength and aerobic
capacity in RTR [22]. The full resistance- and aerobic
training program is shown in Additional files 1 and 2:
Tables S1 and S2.
Maximal muscle strength (1RM) for all exercise ma-
chines (Additional file 1: Table S1) is assessed at base-
line. For maximal muscle strength training, moderate
loading is used (50–60% 1RM), for 2–3 sets of 8–10 rep-
etitions. Higher loads are known to be more appropriate
for maximal muscle strength, however 50–60% 1RM is
used in our protocol as most participants are untrained,
and RTR have increased risk of tendon ruptures. For
local muscle endurance training a light-to-moderate load
is used (25–35% 1RM), for 1–3 sets of 30 repetitions. All
resistance exercise involved exercise machines, no free
weights are used for safety reasons.
The load for the aerobic cycle training is determined
based on the baseline symptom-limited graded maximal
cycle ergometry test. Treadmill walking is performed at
the load at which heart rate is similar to the heart rate
during aerobic cycle-training. If the physiotherapists no-
tice that a subject is training below or above the optimal
intensity (e.g. in case a baseline exercise test is performed
sub optimally), they are allowed to make slight adjust-
ments to the participants’ exercise intensity.
Lifestyle counseling
During the active follow-up, participants are supported to
continue sports activities and keep up daily physical activ-
ity by lifestyle coaches. A total of 5 lifestyle counseling
consultations are scheduled during the entire exercise
intervention and similar for the exercise + diet interven-
tion, see next paragraph: at 6 weeks, 12 weeks, 16 weeks,
6 months, and at 15 months. The first two consultations
are face-to-face and combined with the exercise training
sessions. Consultations at 4 and 6 months are done face-
to-face if possible, otherwise by phone. The final lifestyle
counseling session is face-to-face together with the final
test moment at 15 months. To optimize participant mo-
tivation, the lifestyle counseling is in line with the Self-
Determination Theory, fostering the perceived autonomy,
competence and relatedness [28–30]. Additionally, the
Stages of Change model is applied, and readiness for
change is assessed at the first 2 lifestyle counseling ses-
sions to better tailor the content of the consultations to
the participants' readiness to change their exercise and
physical activity behavior [31]. During these lifestyle coun-
seling sessions a motivational interviewing approach is
used. During the lifestyle counseling participants receive
several tools to stimulate a physically active lifestyle, in-
cluding an information leaflet of the Dutch Kidney Foun-
dation on exercise and physical activity after renal
transplantation [32], a step counter to stimulate physical
activity through self-monitoring, and finally, a hard-copy
log book for educational and motivational purposes. The
log book includes advice on exercise, finding an exercise
buddy, setting personal goals, and tables to log one’s own
exercise behavior.
Exercise + diet intervention
The exercise training program in the exercise + diet
intervention group is identical to that of the exercise
intervention group, and additionally, participants receive
dietary counseling. The dietary counseling runs through-
out the entire 15 months of the study period and con-
sists of a total of 12 counseling sessions with a renal
dietician. The dietary counseling takes place in the hos-
pital face-to-face. If this is not feasible some counseling
sessions are done by phone. The dieticians are trained to
use motivational interviewing techniques which they
apply during the dietary counseling sessions.
Goals are set to improve nutrition status to preserve
renal function, to prevent weight gain, type 2 diabetes,
and hypercholesterolemia. These goals are set together
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with the participant to facilitate an autonomy supportive
counseling climate [33]. A three-day food diary is used
as input during the dietary consultations and for per-
sonal goal setting. Participants also receive a food log-
book which contains information and exercises to help
the participant set diet goals. During the dietary counsel-
ing sessions, special attention is given to salt intake,
whole-wheat grains and fruit and vegetable intake, intake
of saturated and unsaturated fat, and the use of sugar-rich
products, sugar-sweetened beverages (soft drinks, sweet-
ened dairy drinks and fruit juices) and preventing overeat-
ing. In addition, participants are reminded of their
physical activity goals, and the importance of protein in-
take for maintaining and increasing muscle mass. In case
of disease after transplantation, for example infections, the
dietician assists the patient in maintaining an energy- and
protein-rich diet to prevent further deterioration or de-
cline in muscle mass.
Dietary counseling session 9 (of total 12) is a group
meeting for which the participants are encouraged to
bring significant others such as their partner or other
supportive family members. The dietary counseling is in
line with the 2006 Guidelines for a Healthy Diet by the
Dutch Food and Nutrition Council [34], supplemented
with diet guidelines for RTR [35] and diet guidelines for
the prevention of type 2 diabetes [36] and cardiovascular
risk [37].
Immunosuppressive medication regimen
All participants receive standard immunosuppressive
treatment. In the UMCG this consists of induction ther-
apy with methylprednisolone (40 mg) and basiliximab
(20 mg) on day 1 and at day 4 post-operation. This is
followed by a maintenance immunosuppressive regimen
of tacrolimus, mycophenolate mofetil and prednisolone,
tapered to a maintenance dose of 5-10 mg per day. Stand-
ard immunosuppressive treatment in the MUMC consists
of no induction therapy, methylprednisolone 125 mg per
day intravenous during the first 48 h, starting periopera-
tive, followed by a maintenance immunosuppressive regi-
men of mycofenolate mofetil 2dd 1000 mg, after two
weeks 2dd 500 mg and tacrolimus .
Standard immunosuppressive treatment in the AMC
consisted of induction therapy CD25 mAB intravenous
prior to transplantation, and at day 4 post-operation.
Methyl prednisolone 2 × 50 mg intravenous during the
first 48 h, starting perioperative. This is followed by a
maintenance immunosuppressive regimen of tacrolimus,
mycophenolate mofetil and prednisolone tapered to a
dose of 5–10 mg per day.
Outcomes
The primary outcome is the subdomain physical func-
tioning of quality of life of the SF-36. Secondary
outcomes include other evaluations of quality of life (SF-
36, KDQOL-SF, EQ-5D), muscle strength (Additional file
1: Table S1), aerobic capacity, physical activity, gain in
adiposity (body fat percentage by bio-electrical imped-
ance assessment, BMI, waist circumference), and cardio-
metabolic risk factors (blood pressure, lipids, glucose
metabolism). Furthermore, data on renal function, med-
ical history, medication, psychosocial factors (motivation,
kinesiophobia, coping style), nutrition knowledge, nutri-
tion intake, nutrition status, fatigue, work participation,
process evaluation and cost-effectiveness are collected.
Effectiveness of the diet intervention will be determined
at 15 months. To study barriers and success factors re-
garding lifestyle counseling in RTR, data are gathered on
psychological factors including motivation, kinesiopho-
bia, and coping style. A comprehensive overview of the
measurements in the ACT trial is shown in Table 1.
Self-reported physical functioning and quality of life
The physical functioning subscale of the short form 36
(SF-36), version 2 is used as a measure of physical func-
tioning in the present study. Besides subjective measures
of physical functioning, objective assessments are also
included in the study as described below.
Furthermore, Quality of life is measured by the SF-36,
the Kidney Disease Quality of Life Instrument - Short
Form (KDQOL-SF) and the EuroQol (EQ-5D). SF-36
consists of 36 items which measure self-reported phys-
ical functioning, social functioning, role limitations due
to physical and emotional problems, mental health, vital-
ity, pain and general health on a scale of 0–100. The
scores are added up into two summary scores, the phys-
ical component summary (PCS) and the mental compo-
nent summary (MCS). The KDQOL-SF contains 13
items targeted at quality of life related to matters of spe-
cial relevance for renal patients, such as disease burden
and social interaction [38]. The KDQOL-SF has been
translated into Dutch and validated in Dutch patient
population [39]. The EQ-5D is a general questionnaire
and contains questions on mobility, self-care, usual ac-
tivities, pain/discomfort and anxiety/depression and a
VAS scale for self-rated health.
Objective measures of physical functioning
Muscle strength
Maximal muscle strength is assessed for multiple muscle
groups (Additional file 1: Table S1). Maximal muscle
strength of knee extensors, knee flexors, back and chest
muscles are included as an outcome measure. Maximal
muscle strength is determined using the one-repetition
maximum (1RM) method under supervision of a quali-
fied physiotherapist. The 1RM refers to the resistance at
which the participant is only just able to perform the ex-
ercise correctly. For each strength test, the
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Table 1 Overview of measurements in the ACT trial
Outcome Method Time points
Quality of life T0, T3, T6, T15
Physical functioning SF-36 PF subscale [72, 73]
Other subdomains and total SF-36 [72, 73]
Renal specific KDQOL-SF [39]
General EQ-5D [69]
Physical function
Aerobic capacity VO2peak ergometer test [74] T0, T3, T6, T15
Sub-maximal ergometer test T0, T3, T6, T15
Muscle strength 1RM tests for leg extension, leg curl, chest
press, close-grip pull-down
T0, T3, T6, T15
Balance and mobility Short Physical Performance Battery [41] T0, T15
Physical activity level Baecke questionnaire [42] T0, T3, T6, T15
Step counter (Yamax SW200) [75] T0, T3, T6, T15
Body composition
Weight, Height, WC, HC WHO guidelines [76] T0, T3, T6, T15
Nutritional status (undernutrition) SGA [77] T0, T15
Body fat percentage BIA (Biostat Quadscan 4000, Douglas, Isle of Man) T0, T3, T6, T15
Muscle mass BIA (Biostat Quadscan 4000, Douglas, Isle of Man) T0, T3, T6, T15
24-h creatine excretion [44, 78] T0, T3, T6, T15
Cardiometabolic risk factors
Blood pressure (Speidel & Keller Maxi Stabil 3) T0, T3, T6, T15
Blood lipids TG, TC, HDL-C, LDL-C in fasting serum levels
(Cholesterol oxidase-phenol aminophenazone method,
MEGA AU 510; Merck Diagnostica, Darmstadt, Germany)
T0, T3, T6, T15
Glucose metabolism
Insulin resistance HOMA-IR (fasting glucose, insulin) T0, T3, T15 (all)
(Postprandial) hyperglycemia 7-point oral glucose tolerance test [47] T0, T3, T15
(subgroup)
Renal parameters
Medical history Patient files T0
Renal function eGFR, albuminuria T0, T3, T6, T15
Medical history Patients files T0, T3, T6, T15
Medication
Immunosuppressants Patient files, plasma drug levels T0, T3, T6, T15
Other (e.g anti-hypertensives, anti-diabetics,
statins)
Patient files T0, T3, T6, T15
Psychological dimensions of lifestyle behavior
Autonomy, competence,
relatedness in general
Basic Needs Satisfaction in General Scale (BNSG [48, 49]) T0
Autonomy, competence,
relatedness in exercise
Basic Psychological Needs in Exercise Scale (BPNES [50])* T3, T6, T15
Self-regulation of exercise Behavioral Regulation in Exercise Questionnaire (BREQ-2 [51]) T0, T3, T6, T15
Self-regulation and autonomy Treatment Self-Regulation Questionnaire (TSRQ [52]) T3, T6
Motivation for exercise Intrinsic Motivation Inventory (IMI [53]) adapted for exercise. T3, T15
Motives for exercise Exercise Motivation Inventory (EMI-2 [54]) T0, T6
Perceived competence Perceived Competence Scale (PCS [56, 55]) T3, T6, T15
Perceived autonomy support Health Care Climate Questionnaire (HCCQ [55, 57])* T3, T6, T15
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physiotherapist estimates the 1RM of the subject for the
particular exercise machine. The increments are chosen
in such a way that the participant reaches 1RM after 3–
5 one-repetition sets.
Aerobic capacity
Aerobic capacity is determined by symptom-limited
graded cycle ergometry, which is commonly used in
renal transplant patients and considered the gold stand-
ard for determining aerobic capacity [1]. The test deter-
mines the maximal workload (Wpeak) and maximal
oxygen uptake (VO2peak) using a respiratory gas
analyzer (Cortex Metalyzer 3B breath analyser, Cortex
Biophysik GmbH, Leipzig, Germany). VO2peak indicates
the peak amount of oxygen that the body is able to
utilize during sustained physical exertion [1]. The cycle
ergometers used for all participants is a Lode Corival
906900 (Lode B.V., Groningen, Netherlands). After a
period of rest and 1 min pedaling without workload, the
bicycle workload is increased gradually every minute by
10 to 25 W depending on the participants’ expected ex-
ercise capacity. The incremental increase in workload is
done in such a way that maximal exercise capacity is
reached within 8–12 min after starting the exercise test.
The workload during the test is blinded for the partici-
pant. Participants cycle at a cadence of 60–70 rotations
per minute until exhaustion. The maximal cycle
ergometry tests are medically supervised by a sports
physician. Before and during the test, the participant’s
heart function is monitored using ECG-monitoring. In
addition, heart rate, blood pressure and oxygen satur-
ation are monitored. The test is stopped when ECG ab-
normalities occur, systolic blood pressure rises over
250 mmHg or diastolic blood pressure rises over
120 mmHg, or if blood pressure falls with more than
20 mmHg.
The sub-maximal exercise test is performed on a gen-
eral fitness cycle-ergometer under supervision of a quali-
fied physiotherapist. It consists of a 2 min warm-up,
10 min cycling at 50% Wpeak, followed by 70% of
Wpeak at 60–70 rpm until exhaustion, but for a max-
imum of 20 min. A longer test duration indicates better
exercise capacity. Heart rate and blood pressure are
monitored during the submaximal cycle ergometry using
an Omron M6 (Omron, Tokyo, Japan).
Balance and mobility
The Short Physical Performance Battery (SPPB) is used to
determine lower extremity function as a measure for bal-
ance and mobility. SPPB is a common and reliable stan-
dardized measure of balance, gait speed, and chair stand
tests used to measure physical performance [40, 41].
For daily physical activity, the Baecke questionnaire is
used to assess habitual PA with questions on PA in
Table 1 Overview of measurements in the ACT trial (Continued)
Fear of movement Tampa Scale of Kinesiphobia – DV [58] T0, T3, T15
Other questionnaires
Demographics Date of birth, marital status T0, T3, T6, T15
Sex, education, ethnicity T0
Coping style Utrecht Coping List [59] T0
Nutrition knowledge Based on questions of national dietary guidelines survey T0, T15
Work-induced fatigue Need for Recovery Scale (NFR [66]) T0, T3, T6, T15
Chronic fatigue Dutch Checklist Individual Resilience (CIS-20 [60–62]) T0, T3, T6, T15
Work participation NIVEL questionnaire [68] T0, T3, T6, T15
Dietary intake
Self-reported intake 3-day food diary T0, T3, T6, T15
Intake biomarkers 24-h excretion of sodium, potassium, urea T0, T3, T6, T15
Smoking and alcohol consumption Questionnaire T0, T6, T15
Process evaluation Questions about tools, coaches and the program for the patient*
Questions about tools, time/number of visits, and the program for the
professional
Focus groups with patients*
Focus group with professionals
T15
Cost-effectiveness
Quality of life EQ-5D [69] T0, T3, T6, T15
Care consumption, intervention
costs
Standard Dutch Questionnaire T0, T3, T6, T9, T12,
T15
* These outcomes were only assessed in the intervention groups. Abbreviations: T#, months after baseline
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different domains such as school/work, sports practice
and leisure-time physical activity [42]. Responses are
combined producing an overall habitual activity score.
This has been validated against the doubly-labeled water
method, showing a strong correlation (r = 0.69,
p = <0.001) [43]. A validated spring-levered step counter
(Yamax Digiwalker SW-200, Lees Summit, Missouri
(YX200)) is used to objectively measure daily steps as
an objective measure of physical activity level. Partici-
pants are instructed to wear the step counter for
5 days, and record the date, number of steps at each
of the five days, as well as the time in minutes spent
on cycling, swimming and fitness on each of those
5 days.
Body composition and nutrition status
Body composition is estimated using a multi-frequency
bio-electrical impedance device (BIA, Biostat Quadscan
4000, Douglas, Isle of Man) at 5, 50, 100 and 200 Hz,
which allows for distinction between body fat mass and
lean body mass taking into account differences in vol-
ume status. BIA is used to estimated fat mass, fat free
mass and body fat percentage. Muscle mass is estimated
as fat free mass from BIA and from 24-h urinary creatin-
ine excretion. The 24-h creatinine excretion is consid-
ered a reliable measure of muscle mass even in patients
with advanced renal failure, in elderly people, and in pa-
tients with wasting conditions [3, 44]. Anthropometry
measures include bodyweight, height, waist- and hip cir-
cumference. All anthropometry measures are done
twice. Bodyweight is measured in lightweight clothing
without shoes, preferably in the morning, on a calibrated
scale (Seca 877, Seca GMBH, Hamburg, Germany), to
the nearest 0.1 kg. Height is measured using a wall-
secured stadiometer (Seca 222, Seca GMBH, Hamburg,
Germany). Waist circumference is measured with the
subject in standing position at the level midway between
the lowest rib and iliac crest at the end of an expiration
to the nearest 0.1 cm. Waist circumference is also mea-
sured in participants with polycystic kidney disease
which may create noise in the data, although in case a
participant had polycystic kidney disease this is clearly
defined in our dataset. Hip circumference is measured
as the maximum circumference over the trochanter
major to the nearest 0.1 cm. A tape with standardized
retraction mechanism (Seca 201, Seca GMBH, Hamburg,
Germany) is used. Nutrition status is assessed by sub-
jective global assessment (SGA) [45]. The SGA consists
of an anamnesis (questions about change in bodyweight,
food intake and gastrointestinal symptoms) and a phys-
ical examination (subcutaneous fat, muscular atrophy of
the upper and lower body) resulting in an SGA-
classification (seriously malnourished, moderately mal-
nourished or normally nourished).
Cardiometabolic risk factors
Blood samples are collected after an overnight fast and
assayed for triglycerides, total cholesterol, HDL- and
LDL cholesterol for lipid profile and for glucose and in-
sulin to calculate insulin resistance (HOMA2-index)
[46]. Impaired glucose metabolism is measured using 7-
timepoint Oral Glucose Tolerance Test [47]. After fast-
ing blood sampling, the participant consumes a 300 ml
glucose solution which contains 75 g of glucose (82.5 g
glucose monohydrate). After glucose ingestion, blood is
drawn at 10, 20, 30, 40, 60, 90 and 120 min. During the
test participants are not allowed to eat or drink, except
for a limited amount of water. Blood samples are stored
until further analysis. Oral Glucose Tolerance Testing
was performed in a subsample (participants from
University Medical Center Groningen).
Renal parameters
Serum creatinine concentrations are determined using
the Jaffé method. Creatinine clearance is calculated from
24-h urinary creatinine excretion and serum creatinine.
Medical information is collected from the participants’
medical files, including renal parameters (underlying
cause of the renal disease, dialysis duration and type,
transplantation type, time since transplantation), medi-
cation use, hospital admissions, complications after
transplantation, co-morbidities and mortality. Medica-
tion is derived from the participants’ medical records.
Questionnaires
A quite extensive set of questionnaires to address poten-
tial psychological aspects, mostly aspects of motivation,
is included in the questionnaires for participants. Details
about moment of assessment is given in Table 1. The
following questionnaires are included: Basic Needs Satis-
faction in General Scale [48, 49]Basic Psychological
Needs in Exercise Scale [50], Behavioral Regulation in
Exercise Questionnaire version 2 [51], Treatment Self-
regulation Questionnaire [52], Intrinsic Motivation In-
ventory [53], Exercise Motivations Inventory version 2
[54], Perceived Competence Scale [55, 56] and the
Health Care Climate Questionnaire [55, 57]. Further-
more, fear of movement is determined using the 17-item
Tampa Score for Kinesiophobia [58]. Questions are an-
swered on a 4-point likert-type scale ranging from 0 (not
true for me) to 4 (very true for me). Coping style is mea-
sured using the Utrecht Coping List, a Dutch 47-item
questionnaire [59]. Coping style refers to a persons’ spe-
cific efforts to master, tolerate, or reduce stress in stress-
ful conditions. Nutrition knowledge is estimated using
items from a national survey, developed by the
Netherlands Nutrition Center to assess knowledge of the
Dutch dietary guidelines on dietary fibre, fruits, vegeta-
bles, calories, fats, and extended with items about
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potassium and sodium. Chronic fatigue is measured
using the Dutch Checklist Individual Resilience (CIS-20)
[60–62] consisting of 20 items covering the subjective
experience of fatigue, reduction in motivation, reduction
in concentration and reduction in physical activity. CIS-
20 is tested thoroughly in the clinical setting among pa-
tients with chronic fatigue syndrome and other chronic
diseases and healthy controls [63–65]. Work-induced fa-
tigue is assessed by the Need for Recovery scale [66].
This 11-item questionnaire measures fatigue as a result
of exposure to physical and mental demands imposed by
work [66, 67]. Work participation is assessed using a
previously developed questionnaire for patients with
renal disease [68]. Furthermore, the ACT questionnaire
contains questions about demographics, smoking, and
alcohol consumption.
Dietary intake
A three-day food diary is kept for two weekdays and one
weekend day. Participants are instructed to fill out the
food diary accurately using standard supply units or, in
case of deviations, to weigh their food to improve estimate
of consumption. Food diaries are analyzed by a dietitian,
and the nutrition values are calculated using the software
program EvryDietist, 6.4.2.1 (Evry, Alphen aan den Rijn,
Netherlands), using the Dutch Food Composition Data-
base 2016 to calculate macro- and micronutrient intake.
As part of usual care all participants are instructed to col-
lect a 24-h urine sample according to a strict protocol at
the day before their visit to the outpatient clinic, from
which dietary sodium intake is calculated. Twenty-four-
hour urine collections are stored until further analysis.
Process evaluation
Qualitative findings regarding organizing and carrying
out the intervention is derived from focus groups with
the participants, and separately with 1 focus group with
professionals (physiotherapists, dieticians and lifestyle
coaches). All participants that are randomized into the
intervention groups are invited to take part in the focus
group after they have finished the intervention. Each
participant focus group lasts 90 min, during which they
are asked a series of open questions to evaluate the exer-
cise training phase, the follow-up phase, the lifestyle
counseling sessions and dietary counseling sessions. The
focus groups are recorded and the recordings are tran-
scribed for analysis. A focus group with the professionals
will be done at the end of the ACT study.
Health economic analysis
Costs en cost effectiveness of the interventions will be
studied from a societal perspective over a 15 month time
horizon. The effectiveness of the interventions will be
assessed using information about the health-related
quality of life of the participants, measured using the EQ-
5D [69]. This instrument measures health-related quality
of life and 60 translates responses into a utility score. The
EQ-5D measures health in five dimensions of health-
related quality of life (mobility, self-care, usual activities,
pain/discomfort, and anxiety/depression). Dutch-specific
value sets will be used to translate responses into a utility
score. Utility scores will be used to calculate quality-
adjusted life-years (QALYs).
Healthcare consumption is measured using a standard-
ized Dutch questionnaire. This questionnaire measures the
amount of visits to a healthcare provider, and the means of
travelling (i.e. walking/cycling, car, public transport, taxi or
other). Unit costs from routinely available sources will be
applied to the number of visits to calculate the total costs
of these visits for each participant. The Dutch manual for
cost-effectiveness analysis is used as a guideline for weigh-
ing the cost items [70, 71]. Additional cost calculations will
be done for the interventions including personnel, mate-
rials, volume and overhead costs. The total costs and
QALYs in the intervention groups will be compared to the
total costs and QALYs in the control group. An incremental
cost-effectiveness ratio (ICER) will be calculated to compare
the exercise intervention, and the exercise + diet interven-
tion with usual care. Furthermore, two cost-utility analyses
will be done with EQ-5D as an outcome measure.
Statistical analyses
Short term differences between groups will be tested
using students T-test or linear regression, and long term
differences will be tested using General Linear Mixed
models. Time will be analyzed for exercise intervention
(phase 1) and maintenance period (phase 2). Centers will
be taken into account as random factor. Intention to
treat principle will be applied in primary analyses. Per
protocol analysis will be based on completion of the
exercise training sessions, and attendance of dietary
counseling sessions. Stratified analysis are foreseen for
time after transplantation, socio-economic status and
immunosuppressive regime. Furthermore, potential pre-
set determinants of intervention outcome will be evalu-
ated in a GLM model: gender, age, coping style, fear of
movement, work participation and clinical factors.
Discussion
The aim of this RCT is to evaluate the effects and cost-
effectiveness of an exercise only intervention and an exercise
+ diet intervention on physical functioning, quality of life
and -as an important secondary aim- post-transplantation
weight gain and cardiometabolic risk after renal transplant-
ation. It will cover a large range of relevant patient-centered
and clinical outcomes, as well as cost-effectiveness analyses,
to provide guidance for evidence-based care.
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The ACT trial is a pragmatic RCT. This means that
already in the trial phase, the intervention is aimed at and
implemented by regular staff members in daily care. This
also implies that the control condition can be less controlled
than it would have been in an explanatory trial [24, 25].
In the present study we strive for a set-up to maximize
external validity within the context of renal transplant
care in the Netherlands, by working with physiothera-
pists in existing rehabilitation centers and physiotherapy
practices, and with dieticians in the field of renal care.
Hereby generalizability to the clinical setting in RTR
population is offered, providing widely applicable high-
quality evidence for healthcare policy makers. Evidence-
based behavioral components are included in the study
to facilitate behavior change and long-term behavior
maintenance.
Another strength is the application of focus groups
with both the participants as well as the various health-
care professionals, as these qualitative data will provide a
wealth of detailed information of patients’ and profes-
sionals’ attitudes toward and experiences with the inter-
vention, supporting future implementation.
The present RCT includes a relatively high number of
participants. The exercise training is delivered in larger
groups at rehabilitation centers, and in smaller groups
with physiotherapy practices. Sub-analyses may reveal
differences in outcome between settings. The diet inter-
vention is done by renal dieticians which are familiar
with this patient population. Other strengths include
gold standard measurement of aerobic capacity, object-
ive measurement of physical activity using step counters,
bio-impedance and BMI measured by dieticians, and the
use of 24-h urine biomarkers.
A limitation of the present study is its complexity. The
RCT involves skills and experience of multiple healthcare
professionals working at different centers, making it diffi-
cult to standardize intervention delivery. Another limita-
tion is that the exercise intervention and exercise with
dietary counseling groups are combined. This may lead to
contamination between groups, as participants of the ex-
ercise + diet group may share dietary advice with the exer-
cise only group e.g. during the exercise training sessions.
Furthermore, participants entering the ACT trial already
have a certain degree of motivation to improve their
health and fitness through lifestyle. Therefore, control par-
ticipants may have worked on their health and fitness in
alternative ways. Another limitation is that the study took
place only in the Netherlands.
The present study aims to provide evidence needed to
guide decision making by clinicians and policy-makers
in post-transplantation care. Furthermore, it will help
develop guidelines for post-transplantation care in the
Netherlands to further improve long-term outcomes of
renal transplantation.
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